Developing Thailand with the BCG economic model aims to drive the Thai economy to sustainability in all dimensions. One of the important fields –medicine and vaccines – is being supported by relevant agencies, especially in “biopharmacy development,” which still has access problems. As the drugs are high-priced, the country’s goal is to produce nine biological medicines within five years, which means that it will be able to reduce imports by 7,500 million baht and increase the ability to export medicines worth 10 billion baht, which Thailand has never been able to do before. Given below are the directions it will be driven:
Source: National Science and Technology Development Agency (NSTDA)
Tel: +66 2 564 8000